INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2007

Most antioxidant vitamin trials have failed to reduce cardiovascular morbidity and mortality, with some monotherapies showing potential harm.

Extensive experimental data indicate a central role for oxidative stress in atherogenesis. However, most antioxidant vitamin trials have failed to lower cardiovascular morbidity and mortality, and monotherapy with certain vitamins like vitamin E may be detrimental. The review suggests that more rigorous clinical trial designs and a multifaceted antioxidant approach may be necessary to determine antioxidant utility in cardiovascular disease.

Study type
Narrative review
Who was studied
Human clinical trials of antioxidant vitamins
What was measured
Cardiovascular morbidity and mortality

THE PAPER

Atherosclerosis and oxidant stress: the end of the road for antioxidant vitamin treatment?

Thomson MJ, Puntmann V, Kaski JC. Cardiovasc Drugs Ther, 2007.

PubMed 17484034 ↗DOI 10.1007/s10557-007-6027-1 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.